You searched for "foundation"
My top five Apps for UK-based general ophthalmologists
1 October 2021
| Yarrow Scantling-Birch, Rajagopal Govindan, Hasan Naveed
|
EYE - General
The way we interact in society is changing as more of us are becoming ‘digital natives’: individuals who are in close contact to the internet and expect to integrate smart devices with our daily lives. This was stereotypically a term...
Enhancing ophthalmology training: Unleashing the power of simulation
2 August 2024
| Connor Henry-Blake, Emma Pearson, Muhammed Jawad
|
EYE - General
Ethical and practical barriers hinder early surgical experience in ophthalmology training [1], which is problematic when early-career trainees bring a higher risk of poor surgical outcomes and patient harm [2]. The European working time directive and the surgical backlog secondary...
My Top Five: Apps for UK-based general ophthalmologists
1 October 2021
| Yarrow Scantling-Birch, Rajagopal Govindan, Hasan Naveed
|
EYE - General
The way we interact in society is changing as more of us are becoming ‘digital natives’: individuals who are in close contact to the internet and expect to integrate smart devices with our daily lives. This was stereotypically a term...
In conversation with Marc Labetoulle
9 December 2024
| Marc Labetoulle
|
EYE - Cornea
Following the hugely successful 10th Tear Film & Ocular Surface Society (TFOS) 2024 Conference which took place in Venice, Italy between 30 October – 2 November, we managed to have a quick Q&A with presenting attendee, Marc Labetoulle. Delivering his...
LSHTM: Skills for Eye Field Research
28 November 2024
-12 December 2024
This course takes place in November/December each year on Thursdays and Fridays over 3 weeks (5 teaching days and one day for the written assessment). All sessions are delivered face-to-face for the whole day (09:30 - 12:45 and 14:00 -...
Cytotoxic effect of voriconazole on human corneal epithelial cells
Voriconazole is a second-generation synthetic derivative of fluconazole with broadened antifungal spectrum. It is becoming the drug of choice for fungal keratitis. Voriconazole eye drops are not available commercially, thus have to be prepared by diluting the intravenous formulation containing...
The long-term effects of AREDS on AMD progression
1 December 2013
| Brian Ang
|
EYE - Vitreo-Retinal
The Age-Related Eye Disease Study (AREDS) was an 11-centre, double-masked, clinical trial that in 2001 found a high-dose of antioxidant vitamins plus zinc was effective in protecting against progression of age-related macular degeneration (AMD) in patients with moderate to high...
Brolucizumab in age-related macular degeneration, HAWK Study
3 October 2023
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
Neovascular age-related macular degeneration, aflibercept, anti-vascular endothelial growth factor therapy, brolucizumab, commercial formulation
The aim of the study was to collect additional data on efficacy and safety of brolucizumab 6mg intended for commercialization in age-related macular degeneration (AMD) (with an increase in pH and decrease in polysorbate concentration). The HAWK Study was a...
Contemporary glaucoma therapy: spoilt for choice
1 April 2014
| Rod McNeil
|
EYE - Glaucoma
The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...
Internuclear ophthalmoplegia: a case study
3 June 2024
| Miguel Kurc
|
EYE - General
A 44-year-old patient presents with binocular, mostly horizontal diplopia when fixating on moving objects. This has been ongoing for approximately five years. He is known to have multiple sclerosis and had an episode of optic neuritis six years prior in...
Pulling on the heart strings: ophthalmologist fundraises for GOSH
2 April 2021
NIHR Doctoral Fellow Sohaib Rufai is sharing his guitar performances to raise money for Great Ormond Street Hospital Children's Charity.
